Clinical trial
Steroid Treatment for Sickle Cell Pain Crisis
NCT00263562 · Baylor College of Medicine, Other · Terminated
Key facts
| NCT number | NCT00263562 |
|---|---|
| Title | Steroid Treatment for Sickle Cell Pain Crisis |
| Official title | Randomized Trial of High-dose Intravenous Methylprednisolone and Steroid Taper for Vaso-occlusive Crises in Sickle Cell Disease |
| Lead sponsor | Baylor College of Medicine, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sickle Cell Disease, Vaso-occlusive Crisis |
| Intervention type | Drug, Other |
| Interventions | Steroid arm, Placebo |
| Enrollment | 18 |
| Start date | Dec 1, 2005 |
| Primary completion | Jun 13, 2008 |
| Completion | Jun 13, 2008 |
| First posted | Dec 9, 2005 |
| Last update posted | Jul 7, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: